# Biolactis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biolactis

- Industry: Biotechnology
- Headquarters: Laval, Canada
- Website: www.biolactis.com
- Total disclosed funding: $10M
- Latest round: Series A (Feb 7, 2006)
- Investors on record: 1

## About

Biolactis specializes in offering premium domain names that enhance online presence and accessibility for businesses. The company focuses on delivering short, memorable web addresses that cater to diverse client needs.Founded in 1998 in Laval, Canada, Biolactis is dedicated to providing premium domain names. The company successfully raised USD 10.000 mn in Series A funding on February 7, 2006, led by Inventages Venture Capital. No significant pivots or changes in strategy have been documented.Biolactis.com is primarily known for its premium domain name offering, characterized by its short and memorable nine-letter structure coupled with a universally recognized '.com' extension. This domain serves as a critical digital asset for businesses seeking to enhance their online presence and accessibility. The core functionality of the domain is to facilitate customer engagement and improve searchability, addressing challenges associated with longer, less memorable domain names that can hinder user navigation and lead to lost opportunities. Biolactis.com targets a diverse client base that includes startups, established businesses, and entrepreneurs across various industries, looking to secure a high-quality web address that aligns with their brand identity. The domain is marketed globally, focusing on key markets such as North America, Europe, and Asia, where digital presence plays a vital role in business success.Revenue generation for Biolactis.com is centered around the sale and leasing of premium domain names, with a clear transaction structure that facilitates both immediate purchase and long-term leasing options. Clients can secure the domain for a one-time fee or opt for a lease-to-own model, allowing for a monthly payment structure, thereby broadening access to potential customers who may prefer lower upfront costs. The pricing strategy includes a discounted purchase price with a certified valuation significantly higher than the sale price, reinforcing the value proposition of the domain. The business model primarily caters to B2B transactions, enabling clients to enhance their digital portfolios through strategic domain acquisitions. The focus on a high-quality, easily pronounceable domain underscores the intention to drive traffic and engagement, which are essential for customer retention and brand loyalty.In February 2006, Biolactis raised USD 10.000 mn in Series A financing led by Inventages Venture Capital. The company plans to utilize this funding to enhance its offerings and expand into new markets. Future growth strategies include the launch of additional premium domain names tailored to emerging businesses and specific sectors, although no exact release dates have been provided. The company is particularly targeting expansion in key markets across North America, Europe, and Asia over the coming years.

## Funding rounds

- Series A, Feb 7, 2006, $10M — Inventages Venture Capital

## Investors

- Inventages Venture Capital (https://capitalatlas.ai/funds/inventages-venture-capital) — Series A